Description: WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Home Page: www.wuxibiologics.com
No. 108, Meiliang Road
Wuxi,
214092
China
Phone:
86 510 8183 1205
Officers
| Name | Title |
|---|---|
| Dr. Ge Li Ph.D. | Founder & Chairman |
| Dr. Zhisheng Chen | CEO & Exec. Director |
| Dr. Weichang Zhou Ph.D. | Pres of Global Biologics Devel. & Operations, CTO and Exec. Director |
| Mr. Ming Tu | CFO & Exec. VP |
| Ms. Tang Shaogui M.B.A. | VP and Head of Global Communications, Operations, Marketing & ESG |
| Dr. Jijie Gu | Exec. VP & Chief Scientific Officer |
| Ms. Eileen Wang | IR Sr. Director |
| Ms. Cong Ding J.D. | VP & Head of Legal Department |
| He Wang | Chief Compliance Officer, Sr. VP & Head of Global Compliance and Risk Management |
| Ms. Li Xiong | VP & Head of Global HR |
Exchange: HK
Country: HK
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 30.9598 |
|---|---|
| Trailing PE: | 65 |
| Price-to-Book MRQ: | 6.1283 |
| Price-to-Sales TTM: | 16.5047 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10593 |